Skip to main content
SpringerLink
Log in

Role for Surgical Cytoreduction in Multimodality Treatments for Cancer

  • Original Article
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987; 206: 358–65.

    CAS  PubMed  Google Scholar 

  2. Kirsh MM, Rotman H, Bove E, et al. Major pulmonary resection for bronchogenic carcinoma in the elderly. Ann Thorac Surg 1976; 22: 369–73.

    Article  CAS  PubMed  Google Scholar 

  3. Foster JH. Survival after liver resection for secondary tumors. Am J Surg 1978; 135: 389–94.

    CAS  PubMed  Google Scholar 

  4. Muss HB. Chemotherapy of Gynecologic Cancer. 2nd ed. New York: Wiley-Liss, 1990.

    Google Scholar 

  5. Pollock RE, Roth JA. Cancer-induced immunosuppression: implications for therapy? Semin Surg Oncol 1989; 5: 414–19.

    CAS  PubMed  Google Scholar 

  6. Kavanaugh DY, Carbone DP. Immunologic dysfunction in cancer. Hematol Oncol Clin North Am 1996; 10: 927–51.

    CAS  PubMed  Google Scholar 

  7. Rougier P, Bugat R, Douillard JY, et al. Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy. J Clin Oncol 1997; 15: 251–60.

    CAS  PubMed  Google Scholar 

  8. Sugarbaker PH, Schellinx ME, Chang D, Koslowe P, von Meyerfeldt M. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 1996;20:585–91; discussion 592.

    Google Scholar 

  9. Gomez Portilla A, Deraco M, Sugarbaker PH. Clinical pathway for peritoneal carcinomatosis from colon and rectal cancer: guidelines for current practice. Tumori 1997; 83: 725–8.

    CAS  PubMed  Google Scholar 

  10. Eisenkop SM, Friedman RL, Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 1998; 69: 103–8.

    Article  CAS  PubMed  Google Scholar 

  11. Chamberlain RS, Canes D, Brown KT, et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 2000; 190: 432–45.

    Article  CAS  PubMed  Google Scholar 

  12. Miller CA, Ellison EC. Therapeutic alternatives in metastatic neuroendocrine tumors. Surg Oncol Clin North Am 1998; 7: 863–79.

    CAS  Google Scholar 

  13. Bilchik AJ, Sarantou T, Foshag LJ, Giuliano AE, Ramming KP. Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy. Surgery 1997;122:1040–7; discussion 1047–8.

    Google Scholar 

  14. Siperstein AE, Rogers SJ, Hansen PD, Gitomirsky A. Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery 1997;122:1147- 54; discussion 1154–5.

    Google Scholar 

  15. Livraghi T, Lazzaroni S, Meloni F, Torzilli G, Vettori C. Intralesional ethanol in the treatment of unresectable liver cancer. World J Surg 1995; 19: 801–6.

    CAS  PubMed  Google Scholar 

  16. Ajani JA, Carrasco CH, Charnsangavej C, Samaan NA, Levin B, Wallace S. Islet cell tumors metastatic to the liver: effective palliation by sequential hepatic artery embolization. Ann Intern Med 1988; 108: 340–4.

    CAS  PubMed  Google Scholar 

  17. Carrasco CH, Charnsangavej C, Ajani J, Samaan NA, Richli W, Wallace S. The carcinoid syndrome: palliation by hepatic artery embolization. AJR Am J Roentgenol 1986; 147: 149–54.

    CAS  PubMed  Google Scholar 

  18. Curtin JP, Shapiro F. Adjuvant therapy in gynecologic malignancies. Ovarian, cervical, and endometrial cancer. Surg Oncol Clin North Am 1997; 6: 813–30.

    CAS  Google Scholar 

  19. Schwartz PE, Rutherford TJ, Chambers JT, Kohorn EI, Thiel RP. Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival. Gynecol Oncol 1999; 72: 93–9.

    Article  CAS  PubMed  Google Scholar 

  20. Richie JP. Surgical aspects in the treatment of patients with testicular cancer. Hematol Oncol Clin North Am 1991; 5: 1127–42.

    CAS  PubMed  Google Scholar 

  21. Christmas TJ, Mannion EM, Bower M. The current role of surgery in the management of residual disease. Curr Opin Urol 1999; 9: 439–42.

    CAS  PubMed  Google Scholar 

  22. Tafra L, Dale PS, Wanek LA, Ramming KP, Morton DL. Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax. J Thorac Cardiovasc Surg 1995;110:119–28; discussion 129.

    Google Scholar 

  23. Wong JH, Skinner KA, Kim KA, Foshag LJ, Morton DL. The role of surgery in the treatment of nonregionally recurrent melanoma. Surgery 1993; 113: 389–94.

    CAS  PubMed  Google Scholar 

  24. Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 1998;187:88–92; discussion 92–3.

    Google Scholar 

  25. Dousset B, Saint-Marc O, Pitre J, Soubrane O, Houssin D, Chapuis Y. Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation. World J Surg 1996;20:908–14; discussion 914–5.

    Google Scholar 

  26. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101–8.

    CAS  PubMed  Google Scholar 

  27. Fong Y, Kemeny N, Paty P, Blumgart LH, Cohen AM. Treatment of colorectal cancer: hepatic metastasis. Semin Surg Oncol 1996; 12: 219–52.

    CAS  PubMed  Google Scholar 

  28. Cady B, McDermott WV. Major hepatic resection for metachronous metastases from colon cancer. Ann Surg 1985; 210: 204–209.

    Article  Google Scholar 

  29. Kavolius J, Fong Y, Blumgart LH. Surgical resection of metastatic liver tumors. Surg Oncol Clin North Am 1996; 5: 337–352.

    CAS  Google Scholar 

  30. Ebara M, Ohto M, Shinagawa T, et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 1986; 90: 289–98.

    CAS  PubMed  Google Scholar 

  31. Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol 1999; 72: 278–87.

    CAS  PubMed  Google Scholar 

  32. Curtin JP, Malik R, Venkatraman ES, Barakat RR, Hoskins WJ. Stage IV ovarian cancer: impact of surgical debulking [see comments]. Gynecol Oncol 1997; 64: 9–12.

    CAS  PubMed  Google Scholar 

  33. Liu PC, Benjamin I, Morgan MA, King SA, Mikuta JJ, Rubin SC. Effect of surgical debulking on survival in stage IV ovarian cancer [see comments]. Gynecol Oncol 1997; 64: 4–8.

    CAS  PubMed  Google Scholar 

  34. Janicke F, Holscher M, Kuhn W, et al. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer 1992; 70: 2129–36.

    CAS  PubMed  Google Scholar 

  35. Bertelsen K. Tumor reduction surgery and long-term survival in advanced ovarian cancer: a DACOVA study. Gynecol Oncol 1990; 38: 203–9.

    Article  CAS  PubMed  Google Scholar 

  36. McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990; 108: 1091–6.

    CAS  PubMed  Google Scholar 

  37. Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995;169:36–42; discussion 42–3.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York

    Martin D. McCarter MD & Yuman Fong MD

  2. Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021

    Yuman Fong MD

Authors
  1. Martin D. McCarter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuman Fong MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuman Fong MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McCarter, M.D., Fong, Y. Role for Surgical Cytoreduction in Multimodality Treatments for Cancer. Ann Surg Oncol 8, 38–43 (2001). https://doi.org/10.1007/s10434-001-0038-0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-001-0038-0

Key Words

Search

Navigation